Amphastar Pharma (AMPH) Tops Q3 EPS by 1c

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.12, $0.01 better than the analyst estimate of $0.11. Revenue for the quarter came in at $75.5 million versus the consensus estimate of $74.73 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood prices $2B convertible notes offering due 2029
• Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs